ID – 1500
ASSOCIATION OF ANTITHROMBIN LEVELS WITH EFFICACY OF FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A OR B, WITH AND WITHOUT INHIBITORS: A PREDICTIVE MODELING APPROACH
G Younga, K Kavaklib, M Shenc, A Srivastavad, J Sune, H Tranf, J Chig, A Young, M Puurunenh, SW Pipei
a Hemostasis and Thrombosis Center, Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California, LA, United States
b Department of Pediatric Hematology and Oncology, Ege University Faculty of Medicine Children's Hospital, Izmir, Turkey
c Department of Internal Medicine, Changhua Christian Hospital, Changhua; Department of Laboratory Medicine and Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
d Department of Hematology, Christian Medical College, Vellore; Centre for Stem Cell Research (inStem), Vellore, India
e Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
f Ronald Sawers Hemophilia Treatment Center, The Alfred, Monash University, Melbourne, Victoria, Australia
g Sanofi, Bridgewater, NJ, United States
h Sanofi, Cambridge, MA, United States
i Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor, MI, United States
Ver más
